An Enzyme from Bacteria able to Destroy Penicillin, Nature, vol.146, issue.3713, pp.677-685, 1940. ,
DOI : 10.1038/146837a0
Paris: Haut Conseil de la Santé Publique; 2013 juill [cité 9 mai 2016] Disponible sur: http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=372 3 Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver, HCSP. Prévention de la transmission croisée des « Bactéries Hautement Résistantes aux antibiotiques émergentes, 2003. ,
RAISIN and Expert Laboratories Groups. Emergence of carbapenemase-producing Enterobacteriaceae in France, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, vol.16, issue.22, 2004. ,
RAISIN -a national programme for early warning, investigation and surveillance of healthcare-associated infection in France, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, vol.14, issue.46, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00448364
Carbapenem-resistant Enterobacteriaceae and the correlation between carbapenem and fluoroquinolone usage and resistance in the US military health system, Diagnostic Microbiology and Infectious Disease, vol.81, issue.2, pp.119-144, 2015. ,
DOI : 10.1016/j.diagmicrobio.2014.09.017
Carriage and Cross???Border Exchanges: Eight???Year Surveillance in a Large French Multihospitals Institution, Journal of Travel Medicine, vol.19, issue.5, pp.320-323, 2012. ,
DOI : 10.1111/j.1708-8305.2012.00641.x
The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide, Clinical Microbiology and Infection, vol.20, issue.9, pp.821-851, 2014. ,
DOI : 10.1111/1469-0691.12719
Carbapenemases: the versatile beta-lactamases, 440?458, table of contents, 2007. ,
DOI : 10.1128/cmr.00001-07
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1932750
The Association Between Colonization With Carbapenemase-Producing Enterobacteriaceae and Overall ICU Mortality, Critical Care Medicine, vol.43, issue.6, pp.1170-1177, 2015. ,
DOI : 10.1097/CCM.0000000000001028
??-LACTAMASES, British Medical Bulletin, vol.40, issue.1, pp.18-27, 1984. ,
DOI : 10.1093/oxfordjournals.bmb.a071942
Extended-Spectrum Beta-Lactamases, Seminars in Respiratory and Critical Care Medicine, vol.24, issue.1, pp.79-88, 2003. ,
DOI : 10.1055/s-2003-37919
The CTX-M ??-lactamase pandemic, Current Opinion in Microbiology, vol.9, issue.5, pp.466-75, 2006. ,
DOI : 10.1016/j.mib.2006.08.011
Addressing the challenge of extended-spectrum beta-lactamases, Curr Opin Investig Drugs Lond Engl févr, vol.10, issue.2, pp.172-80, 2000. ,
URL : https://hal.archives-ouvertes.fr/hal-00464775
Recommandations de bon usage des carbap??n??mes, Antibiotiques, vol.12, issue.4, 2010. ,
DOI : 10.1016/j.antib.2010.09.002
Extended-spectrum beta-lactamases and the permeability barrier, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. janv, vol.14, issue.1, pp.82-91, 2008. ,
Novel Carbapenem-Hydrolyzing ??-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae, Antimicrobial Agents and Chemotherapy, vol.45, issue.4, pp.1151-61, 2001. ,
DOI : 10.1128/AAC.45.4.1151-1161.2001
IBC-1, a Novel Integron-Associated Class A beta -Lactamase with Extended-Spectrum Properties Produced by an Enterobacter cloacae Clinical Strain, Antimicrobial Agents and Chemotherapy, vol.44, issue.9, pp.2247-53, 2000. ,
DOI : 10.1128/AAC.44.9.2247-2253.2000
Biochemical Sequence Analyses of GES-1, a Novel Class A Extended-Spectrum beta -Lactamase, and the Class 1 Integron In52 from Klebsiella pneumoniae, Antimicrobial Agents and Chemotherapy, vol.44, issue.3, pp.622-654, 2000. ,
DOI : 10.1128/AAC.44.3.622-632.2000
Metallo-??-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily, Biochemical Pharmacology, vol.74, issue.12, pp.1686-701, 2007. ,
DOI : 10.1016/j.bcp.2007.05.021
ARI 1: ??-lactamase-mediated imipenem resistance in Acinetobacter baumannii, International Journal of Antimicrobial Agents, vol.2, issue.2, pp.81-88, 1993. ,
DOI : 10.1016/0924-8579(93)90045-7
Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae, Antimicrobial Agents and Chemotherapy, vol.48, issue.1, pp.15-22, 2004. ,
DOI : 10.1128/AAC.48.1.15-22.2004
Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss, International Journal of Antimicrobial Agents, vol.31, issue.6, pp.523-529, 2008. ,
DOI : 10.1016/j.ijantimicag.2008.01.017
Chromosome-Encoded Ambler Class D ??-Lactamase of Shewanella oneidensis as a Progenitor of Carbapenem-Hydrolyzing Oxacillinase, Antimicrobial Agents and Chemotherapy, vol.48, issue.1, pp.348-51, 2004. ,
DOI : 10.1128/AAC.48.1.348-351.2004
détection des souches d'entérobactéries productrices d'une carbapénèmase ,
Rapid detection of carbapenemase-producing Enterobacteriaceae from blood cultures, Clinical Microbiology and Infection, vol.20, issue.4, pp.340-344, 2014. ,
DOI : 10.1111/1469-0691.12318
Rapid Identification of Carbapenemase Types in Enterobacteriaceae and Pseudomonas spp. by Using a Biochemical Test, Antimicrobial Agents and Chemotherapy, vol.56, issue.12, pp.6437-6477, 2012. ,
DOI : 10.1128/AAC.01395-12
Prevalence and molecular characterization of Enterobacteriaceae producing NDM-1 carbapenemase at a military hospital in Pakistan and evaluation of two chromogenic media, Diagnostic Microbiology and Infectious Disease, vol.75, issue.2, pp.187-91, 2013. ,
DOI : 10.1016/j.diagmicrobio.2012.11.006
Prevalence of NDM-1 carbapenemase in patients with diarrhoea in Pakistan and evaluation of two chromogenic culture media, Journal of Applied Microbiology, vol.50, issue.3, pp.1810-1816, 2013. ,
DOI : 10.1111/jam.12171
OXA-48-like carbapenemases: the phantom menace, Journal of Antimicrobial Chemotherapy, vol.67, issue.7, pp.1597-606, 2012. ,
DOI : 10.1093/jac/dks121
URL : http://jac.oxfordjournals.org/cgi/content/short/67/7/1597
Carbapenem use in French hospitals: A nationwide survey at the patient level, International Journal of Antimicrobial Agents, vol.46, issue.6, pp.707-719, 2015. ,
DOI : 10.1016/j.ijantimicag.2015.08.013
URL : https://hal.archives-ouvertes.fr/hal-01217126
Demographic and infection characteristics of patients with carbapenem-resistant Enterobacteriaceae in a community hospital: Development of a bedside clinical score for risk assessment, American Journal of Infection Control, vol.44, issue.2, pp.134-141, 2016. ,
DOI : 10.1016/j.ajic.2015.09.006
Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge, American Journal of Infection Control, vol.41, issue.3, pp.190-194, 2013. ,
DOI : 10.1016/j.ajic.2012.09.020
Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study, The Lancet Infectious Diseases, vol.11, issue.5, pp.355-62, 2011. ,
DOI : 10.1016/S1473-3099(11)70059-7
Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, vol.19, issue.14, 2012. ,
Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae, Antimicrob Agents Chemother. sept, vol.40, issue.9, pp.2080-2086, 1996. ,
High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics, Clinical Infectious Diseases, vol.61, issue.4, pp.593-600, 2015. ,
DOI : 10.1093/cid/civ333
European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group. Carbapenemaseproducing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, vol.20, issue.45, 2015. ,
Delayed Diagnosis of High Drug???Resistant Microorganisms Carriage in Repatriated Patients: Three Cases in a French Intensive Care Unit: Table 1, Journal of Travel Medicine, vol.22, issue.3, pp.215-222, 2015. ,
DOI : 10.1111/jtm.12194
Measures to eradicate multidrug-resistant organism outbreaks: how much do they cost?, Clinical Microbiology and Infection, vol.22, issue.2, pp.162-163, 2016. ,
DOI : 10.1016/j.cmi.2015.10.001
URL : http://dx.doi.org/10.1016/j.cmi.2015.10.001
Characteristics and costs of carbapenemase-producing enterobacteria carriers (2012/2013), M??decine et Maladies Infectieuses, vol.44, issue.7, pp.321-327, 2012. ,
DOI : 10.1016/j.medmal.2014.06.004
Conclusions., Infection Control & Hospital Epidemiology, vol.46, issue.01, pp.14-23, 2012. ,
DOI : 10.1097/QCO.0b013e32833ae214
Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials, Clinical Infectious Diseases, vol.54, issue.12, pp.1699-709, 2012. ,
DOI : 10.1093/cid/cis270
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404716
Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs, International Journal of Infectious Diseases, vol.39, pp.25-33, 2015. ,
DOI : 10.1016/j.ijid.2015.08.009